Fremanezumab versus placebo for migraine prevention in patients with documented failure to up to four migraine preventive medication classes (FOCUS): a randomised, double-blind, placebo-controlled, phase 3b trial-Reference-Cited by-同舟云学术

Fremanezumab versus placebo for migraine prevention in patients with documented failure to up to four migraine preventive medication classes (FOCUS): a randomised, double-blind, placebo-controlled, phase 3b trial

Published:2019-09 Issue:10203 Volume:394 Page:1030-1040
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Ferrari Michel D,Diener Hans Christoph,Ning Xiaoping,Galic Maja,Cohen Joshua M,Yang Ronghua,Mueller Matthias,Ahn Andrew H,Schwartz Yael Carmeli,Grozinski-Wolff Melissa,Janka Lindsay,Ashina Messoud

Publisher

Elsevier BV

Subject

General Medicine

Reference31 articles.

1. The International Classification of Headache Disorders, 3rd edition (beta version);Cephalalgia,2013

2. Global, regional, and national burden of migraine and tension-type headache, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016;Lancet Neurol,2018

3. Migraine is first cause of disability in under 50s: will health politicians now take notice?;Steiner;J Headache Pain,2018

4. Defining the differences between episodic migraine and chronic migraine;Katsarava;Curr Pain Headache Rep,2012

5. Preventive migraine treatment;Silberstein;Continuum,2015

Cited by 291 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effectiveness and safety of monthly versus quarterly fremanezumab for migraine prevention: An Italian, multicenter, real‐life study;European Journal of Neurology;2024-09-04

2. Effects of fremanezumab on migraine‐associated symptoms and medication use in Japanese and Korean patients with episodic migraine: Exploratory endpoint analysis of a multicenter, randomized, double‐blind, placebo‐controlled trial;Headache: The Journal of Head and Face Pain;2024-09-02

3. International Headache Society Global Practice Recommendations for Preventive Pharmacological Treatment of Migraine;Cephalalgia;2024-09

4. Cluster headache: understandings of current knowledge and directions for whole process management;Frontiers in Neurology;2024-08-21

5. Evidence‐based review and frontiers of migraine therapy;Neurogastroenterology & Motility;2024-08-12